BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
26.49
+0.28 (1.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
BridgeBio Pharma Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$47.92
Upside
+80.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +84.98% | Dec 16, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +81.20% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +69.88% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $49 | Strong Buy | Maintains | $43 → $49 | +84.98% | Nov 25, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +69.88% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +62.33% | Oct 25, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $47 → $46 | Buy | Maintains | $47 → $46 | +73.65% | Oct 17, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $44 | Buy | Initiates | $44 | +66.10% | Oct 16, 2024 |
| Oppenheimer | Oppenheimer | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +62.33% | Oct 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +62.33% | Sep 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +62.33% | Sep 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $70 | Buy | Reiterates | $70 | +164.25% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +62.33% | Sep 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 | Strong Buy | Maintains | $42 | +58.55% | Sep 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $70 | Buy | Reiterates | $70 | +164.25% | Sep 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.